Literature DB >> 2268683

Human erythrocyte Band-3 has an altered N terminus in malaria-resistant Melanesian ovalocytosis.

G L Jones1, H M Edmundson, D Wesche, A Saul.   

Abstract

There is a high prevalence of the erythrocyte polymorphism ovalocytosis associated with reduced susceptibility to malaria in Papua New Guinea. The major erythrocyte integral membrane protein, Band-3, showed markedly increased phosphorylation in whole cells or isolated ghosts from ovalocytic individuals. The cytoplasmic domain of the ovalocyte Band-3 was found to be approx. 3 kDa larger than the normocytic protein. The N-terminal sequence of the ovalocytic Band-3 was different from the reported sequence for human Band-3, suggesting that the increased size results from an N-terminal extension. Since this is the region of Band-3 which is phosphorylated and interacts with the red cell cytoskeleton, it is likely that this alteration in ovalocytic Band-3 is the underlying cause of the diverse alterations in ovalocytic cells including increased phosphorylation, increased membrane rigidity, decreased agglutinability by blood group antibodies and refractoriness to invasion by malarial parasites.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2268683     DOI: 10.1016/0925-4439(90)90009-e

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Decreased rotational diffusion of band 3 in Melanesian ovalocytes from Papua, New Guinea.

Authors:  L Tilley; G B Nash; G L Jones; W H Sawyer
Journal:  J Membr Biol       Date:  1991-04       Impact factor: 1.843

2.  Deletion in erythrocyte band 3 gene in malaria-resistant Southeast Asian ovalocytosis.

Authors:  P Jarolim; J Palek; D Amato; K Hassan; P Sapak; G T Nurse; H L Rubin; S Zhai; K E Sahr; S C Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

3.  Overexpression of AE1 Prague, but not of AE1 SAO, inhibits wild-type AE1 trafficking in Xenopus oocytes.

Authors:  M N Chernova; P Jarolim; J Palek; S L Alper
Journal:  J Membr Biol       Date:  1995-11       Impact factor: 1.843

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.